Search Medical Condition
Please enter condition
Please choose location

Intermittent Claudication Clinical Trials

A listing of Intermittent Claudication medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (22) clinical trials

For more information please visit: http://clinicaltrials.gov/ct2/show/NCT00401518?term=The+Investigational+Plan+for+the+Evaluation+of+the+ACADIA+Facet+Replacement&rank=1

Phase N/A

Treatment of SFA Lesions With 480 Biomedical STANZA Drug-Eluting Resorbable Scaffold (DRS) System

The STANZA DRS system is comprised of a controlled release paclitaxel-eluting bioresorbable scaffold and a delivery system used in the treatment of superficial femoral artery disease.

Phase N/A

ATHERO: Advanced Technology Halting Early Re-Stenosis and Occlusion

Peripheral arterial disease affects more than 12 million Americans, and its incidence is growing annually. The male/female ratio of patients with claudication is just under 2/1. The arteries involved by atherosclerosis involve the arteries to the thigh and leg. These include the femoral and popliteal arteries. Fifty percent of people ...

Phase

Hospital- and Home-based Supervised Exercise Versus UNsupervised Walk Advice For Patients With InTermittent Claudication

Background Intermittent claudication is usually caused by atherosclerotic stenoses and/or occlusions in the arteries to the legs and affects 7% of the Swedish population aged 60 years or more. Evidence-based treatment is best medical treatment (BMT) and exercise therapy. Best medical treatment includes treatment of risk factors for arteriosclerosis. Regarding ...

Phase N/A

The PaWS (Pedometer and Walking Study)

It has been established that exercise therapy has a central role in the management of peripheral arterial disease. Such treatment should be comprised of intermittent walking of sufficient distance to induce significant discomfort, and be carried out over a period of at least several months. Supervised exercise training utilizing intermittent ...

Phase N/A

Lower Extremity Peripheral Arterial Disease and Exercise Ischemia

Primary Outcome Measure : Coefficient of determination between the recovery duration and subsequent walking performance, obtained from individual regression analyses. Secondary outcome measures : Coefficient of determination determined from different curves fitting. Coefficient of correlation between the level of ischemia during recovery and exercise ischemia and pain occurrence during subsequent ...

Phase N/A

Exercise Rehabilitation in Veterans With PAD

Peripheral artery disease (PAD) and its associated declines in physical function impair quality of life (QOL) in nearly 20% of older Veterans and result in substantial VA health care costs. Revascularization addresses the anatomical pathology, but does not restore mobility function and QOL. Optimal therapy may require post-revascularization rehabilitation to ...

Phase N/A

Evaluation of FM220 in Patients With Peripheral Arterial Disease (PAD)

The purpose of this study is to determine whether 12 weeks of daily home use of the FM220 in the most affected leg of patients with PAD and claudication, will improve peak walking time (PWT) at three months as compared with a non-treated control group.

Phase

The Chocolate Touch Study

The primary objective of the Chocolate Touch study is to demonstrate non-inferior safety and non-inferior effectiveness of the Chocolate Touch compared to the Lutonix drug coated balloon catheter. These data are intended to show safety and effectiveness of the Chocolate Touch sufficient to support regulatory approval to market this device ...

Phase N/A

Creatine Supplementation in Patients With Intermittent Claudication.

The aim of this study will be to verify the effect of creatine supplementation associated to clinical treatment of the functional capacity in patients with intermittent claudication. The sample will be composed by patients with intermittent claudication of both sexes. The patients will be ramdomized in a double-blind procedure to ...

Phase N/A